Market closedNon-fractional

Annovis Bio/ANVS

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX

About Annovis Bio

Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for advanced AD.

Ticker

ANVS

Sector

Healthcare

Trading on

NYSE

Industry

Biotechnology

Headquarters

Malvern, United States

Employees

11

Annovis Bio Metrics

BasicAdvanced
$136M
Market cap
-
P/E ratio
-$5.63
EPS
1.76
Beta
-
Dividend rate
$136M
1.76
1.604
0.644
-160.65%
-566.49%
-40.54
-40.54
-3.311
54.14%
67.54%

What the Analysts think about Annovis Bio

Analyst Ratings

Majority rating from 5 analysts.
Buy

Annovis Bio Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
0.00% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$0
NaN%
Net income
-$1M
-95.50%
Profit margin
0.00%
NaN%

Annovis Bio Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 9.85%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$1.07
-$1.63
-$2.24
-$0.72
-
Expected
-$1.14
-$1.09
-$1.30
-$0.80
-$0.47
Surprise
-6.28%
49.50%
71.71%
-9.85%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Annovis Bio stock?

Annovis Bio (ANVS) has a market cap of $136M as of July 14, 2024.

What is the P/E ratio for Annovis Bio stock?

The price to earnings (P/E) ratio for Annovis Bio (ANVS) stock is 0 as of July 14, 2024.

Does Annovis Bio stock pay dividends?

No, Annovis Bio (ANVS) stock does not pay dividends to its shareholders as of July 14, 2024.

When is the next Annovis Bio dividend payment date?

Annovis Bio (ANVS) stock does not pay dividends to its shareholders.

What is the beta indicator for Annovis Bio?

Annovis Bio (ANVS) has a beta rating of 1.76. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.

Buy or sell Annovis Bio stock

Buy or sell Annovis Bio stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing